Jessica Ding

Jessica Ding is an experienced professional in the pharmaceutical and research sectors, currently serving as the Early Detection Strategy Lead at Sanofi since October 2020. In this role, Jessica leads initiatives for proactive intervention in autoimmune Type 1 Diabetes (T1D) in China, focusing on national strategy, cross-functional collaboration, and partnerships to enhance screening models. Previous positions at Sanofi included Senior NPP Manager, where Jessica oversaw product planning for Rare Diseases and Rare Blood Disorders, and roles in strategic and portfolio excellence management. Jessica's earlier experience includes consulting at IQVIA and Euromonitor International, as well as a research assistant position at Georgetown University. Jessica holds a Master of Arts in Applied Economics from Georgetown University, a Bachelor of Business Administration in Human Resources Management from East China Normal University, and has studied Economics at New York University.